Fifth Third Bancorp Increases Holdings in Concentrix Corporation $CNXC

Fifth Third Bancorp lifted its holdings in Concentrix Corporation (NASDAQ:CNXC) by 6,620.3% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 34,139 shares of the company’s stock after acquiring an additional 33,631 shares during the period. Fifth Third Bancorp owned 0.06% of Concentrix worth $934,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in CNXC. AQR Capital Management LLC lifted its holdings in Concentrix by 1.8% in the 3rd quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock worth $202,175,000 after purchasing an additional 75,352 shares in the last quarter. Pzena Investment Management LLC grew its holdings in Concentrix by 0.5% during the 1st quarter. Pzena Investment Management LLC now owns 2,943,212 shares of the company’s stock valued at $80,526,000 after buying an additional 16,016 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Concentrix by 28.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock valued at $103,588,000 after buying an additional 551,778 shares in the last quarter. State Street Corp raised its position in shares of Concentrix by 8.7% during the second quarter. State Street Corp now owns 1,622,854 shares of the company’s stock valued at $85,776,000 after buying an additional 130,529 shares during the last quarter. Finally, Invenomic Capital Management LP raised its position in shares of Concentrix by 6.3% during the fourth quarter. Invenomic Capital Management LP now owns 874,241 shares of the company’s stock valued at $36,351,000 after buying an additional 51,896 shares during the last quarter. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Wall Street Analysts Forecast Growth

CNXC has been the subject of a number of research reports. Barrington Research dropped their target price on shares of Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research report on Tuesday, June 30th. Bank of America decreased their price target on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a research note on Tuesday, June 30th. Zacks Research downgraded shares of Concentrix from a “hold” rating to a “strong sell” rating in a report on Thursday, July 2nd. Robert W. Baird cut their price objective on Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a research report on Tuesday, June 30th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a research report on Monday, April 27th. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $32.75.

Insider Transactions at Concentrix

In related news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the business’s stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the completion of the transaction, the insider owned 2,773,667 shares in the company, valued at $61,714,090.75. The trade was a 68.39% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.90% of the stock is currently owned by insiders.

Concentrix Stock Performance

Shares of NASDAQ:CNXC opened at $22.25 on Monday. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 1.46. Concentrix Corporation has a 12 month low of $19.12 and a 12 month high of $60.96. The company has a market capitalization of $1.36 billion, a price-to-earnings ratio of -1.04, a PEG ratio of 0.41 and a beta of 0.47. The firm’s 50-day moving average is $25.04 and its 200 day moving average is $29.75.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings data on Monday, June 29th. The company reported $2.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.64 by ($0.01). Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The firm had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.47 billion. During the same period in the previous year, the business earned $2.70 EPS. The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. Research analysts predict that Concentrix Corporation will post 9.67 EPS for the current year.

Concentrix Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 4th. Investors of record on Friday, July 24th will be paid a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 6.5%. The ex-dividend date of this dividend is Friday, July 24th. Concentrix’s dividend payout ratio (DPR) is currently -6.75%.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.